Alnylam Pharmaceuticals, Inc.
ALNY
$304.67
$6.092.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.63B | 2.69B | 2.78B | 2.62B | 2.37B |
| Total Receivables | 418.04M | 405.31M | 353.85M | 309.48M | 321.38M |
| Inventory | 65.58M | 78.51M | 75.99M | 83.98M | 93.99M |
| Prepaid Expenses | 152.42M | 116.96M | 145.35M | 154.75M | 201.96M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.27B | 3.30B | 3.36B | 3.17B | 2.99B |
|
|
|||||
| Total Current Assets | 3.27B | 3.30B | 3.36B | 3.17B | 2.99B |
| Net Property, Plant & Equipment | 695.92M | 693.93M | 703.41M | 715.46M | 718.93M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 249.64M | 250.77M | 146.21M | 121.32M | 116.85M |
| Total Assets | 4.21B | 4.24B | 4.21B | 4.01B | 3.82B |
|
|
|||||
| Total Accounts Payable | 97.40M | 88.42M | 70.81M | 73.98M | 78.15M |
| Total Accrued Expenses | 704.17M | 795.16M | 946.17M | 808.64M | 698.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 127.80M | 154.90M | 132.66M | 103.62M | 87.85M |
| Total Finance Division Other Current Liabilities | 146.26M | 147.79M | 71.03M | 69.01M | 76.85M |
| Total Other Current Liabilities | 146.26M | 147.79M | 71.03M | 69.01M | 76.85M |
| Total Current Liabilities | 1.08B | 1.19B | 1.22B | 1.06B | 941.71M |
|
|
|||||
| Total Current Liabilities | 1.08B | 1.19B | 1.22B | 1.06B | 941.71M |
| Long-Term Debt | 2.36B | 2.36B | 2.36B | 2.37B | 2.36B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 230.06M | 229.54M | 236.03M | 239.35M | 237.83M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 428.31M | 398.11M | 358.49M | 352.83M | 505.50M |
| Total Liabilities | 4.10B | 4.17B | 4.17B | 4.01B | 4.04B |
|
|
|||||
| Common Stock & APIC | 7.50B | 7.39B | 7.26B | 7.12B | 6.88B |
| Retained Earnings | -7.35B | -7.29B | -7.20B | -7.09B | -7.08B |
| Treasury Stock & Other | -37.52M | -34.52M | -24.83M | -34.64M | -26.99M |
| Total Common Equity | 115.44M | 67.09M | 32.35M | -3.07M | -219.27M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 115.44M | 67.09M | 32.35M | -3.07M | -219.27M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 115.44M | 67.09M | 32.35M | -3.07M | -219.27M |
|
|
|||||